[1]
Olmedo-Muñoz, M. and Recalde-Navarrete, R. 2023. Cardiometabolic effect of sodium and glucosa cotransporter inhibitors type 2. Salud, Ciencia y Tecnología. 3, (Oct. 2023), 563. DOI:https://doi.org/10.56294/saludcyt2023563.